Posted inHealth
GLP-1 Medications Drive Surge in Revenue for Pharmaceutical Giants
Eli Lilly reported a remarkable 91 percent increase in second-quarter sales for its diabetes medication Mounjaro, reaching $9.94 billion and significantly surpassing Wall Street expectations. This extraordinary financial growth highlights…
